WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.

WuXi AppTec Co., Ltd.

603259

株式のランク #466
WuXi AppTec Co., Ltd., an investment holding company, provides research and... WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally. The company operates through WuXi Chemistry, WuXi Testing, WuXi Biology, and Others segments. It offers contract research, development, and manufacturing organization (CDRMO) services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions which support stand-alone and integrated projects from target discovery to candidate selection and into the clinic. The company also provides laboratory testing services, such as toxicology, DMPK, and bioanalytical services; clinical contract research organization services, including Phase I to Phase IV clinical development services, and bioequivalence for products including pharmaceuticals and biologics; and site management organization, patient recruitment, site start-up, and academic research organization. In addition, it offers services for biology; CDRMO platform for small molecules, oligonucleotides, and peptides; drug research and development testing; and clinical research services. WuXi AppTec Co., Ltd. was founded in 2000 and is headquartered in Shanghai, the People’s Republic of China.
株価
$21.35
時価総額
$52.81B
変化(1日)
-0.21%
変化(1年)
44.57%
国
CN
取引 WuXi AppTec Co., Ltd. (603259)

カテゴリー

Healthcare
WuXi AppTec Co., Ltd.(603259)の発行済株式数
October 2026 時点の発行済株式数 0
WuXi AppTec Co., Ltd. の最新の財務報告および株価によると、現在の発行済株式数は 0 です。October 2026 の終わりには、同社は 0 株の発行済株式 を有していました。発行済株式数は、通常、株式分割や自社株買いによって影響を受けます。
WuXi AppTec Co., Ltd.(603259)の発行済株式数の履歴(2026 ~ 2026)
各年末時点の発行済株式数
年 発行済株式数 変化
提供された日付のデータは十分ではありません。
類似企業や競合他社の発行済株式数
企業 発行済株式数 差 国
371.00M -
US
705.30M -
US
143.28M -
US
282.00M -
US
167.20M -
US